<DOC>
	<DOCNO>NCT02444481</DOCNO>
	<brief_summary>Open prospective multicenter phase IV study patient present symptom bacterial and/or mycotic ( mushroom ) vaginitis 12 day specify product information . Investigators/centers : 20 gynacologists preview study ambulatory treatment . Objectifs study : Principal objectif : Evaluation efficacy treatment clinical symptom bacterial and/or mycotic vaginitis Secondary objectif : Evaluation efficacy treatment eradication diagnose germ Evaluation correspondence efficacy symptom eradication germ . Numbers patient preview : 100 patient evaluation efficacy Criteria evaluation Principal criterion : Clinical efficacy judge investigator Secondary criterion : evaluation clinical symptom judge patient reduction emlimination bacteria germ relationship clinical bacterial result Evaluation tolerance Used Study Drug : Polygynax , vaginal capsule consist Polymyxin 35000 UI , Neomycin 35000UI Nystatin 100000UI Application : vaginal application daily even 12 day Study design : Visit 1 : All patient present clinical symptom , present inclusion criterion none exclusion criterion include study visit 1 receive Polygynax treatment ( one vaginal capsule daily even ) . A vaginal smear obtain . Visit 2 ( optional ) If result bacteriological examination confirm infection germ sensible treatment Polygynax treatment continue . If germ sensible Polygynax present , patient contact stop treatment , come back second visit gynacologist change treatment . The patient continue treatment . Visit 3 : After treatment patient come back last visit . A clinical evaluation vaginal smear control obtain .</brief_summary>
	<brief_title>Open Study Efficacy Local Treatment With Polygynax Bacterial and/or Mycotic Vaginitis</brief_title>
	<detailed_description />
	<mesh_term>Vaginitis</mesh_term>
	<mesh_term>Neomycin</mesh_term>
	<mesh_term>Nystatin</mesh_term>
	<mesh_term>Polymyxins</mesh_term>
	<criteria>Female Aged 18 year 65 year Agreeing provide write informed consent Presenting symptom vaginitis : unaccustomed leucorrhoea , pruritus , burn sensation micturition , dyspareunia . Patients menstrual period , Virgins , Clinically detectable sexually transmissible infection ( STI ) : genital lesion , evocative leucorrhoea , recent history STI ( &lt; 3 month ) , know STI partner , Sexually transmissible disease , include HIV , Pregnancy , Breastfeeding , Known allergy hypersensitivity treatment ingredient treatment , particular , hypersensitivity soya oil , Use male female condom , Use spermicide , Use diaphragm , Clinical symptom nonsensitive bacterial vaginosis : runny unpleasant smell leucorrhoea suggest Gardnerella vaginalis vaginitis , Concomitant topical systemic antiinfective treatment , Topical systemic antiinfective treatment 14 day prior study , Immunodepression major disease render completion study interpretation study result difficult , Immunosuppressant therapy , Chemotherapy , Participation another clinical trial month prior study ,</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Mycotic Vaginitis</keyword>
</DOC>